ArticlePLoS pathogens2025
Small granule protein CP2 of Cryptosporidium translocates to the parasite-host interface during invasion and localizes to parasitophorous vacuole membrane in association with other secretory proteins.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Cryptosporidium secreted proteins form a complex layered interface with the host cell.PLoS pathogens · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Cryptosporidium is a major cause of diarrhea in humans and farm animals for which there are no effective drugs. The parasite resides in a parasitophorous vacuole on the surface of gastrointestinal epithelial cells. Although the parasitophorous vacuole membrane (PVM) plays a critical role in parasite development and survival, its composition and biogenesis are not well understood. In this study, we used reverse genetic tools to investigate the secretion and function of a potential PVM protein called CP2. Endogenous gene tagging revealed that, following biosynthesis, CP2 is stored in the small granules (SG) within sporozoites. Upon invasion of host cells, CP2 is translocated to the parasite-host interface. During intracellular development, CP2 is distributed across the entire PVM in trophozoites and microgamonts, but it is concentrated in the lower PVM, near the attachment zone, in mature meronts and macrogametes. Interestingly, CP2 is dispensable; deleting the CP2 gene did not significantly affect the growth or pathogenicity of a virulent Cryptosporidium strain. CP2 knockout resulted in increased expression of a neighboring gene encoding SG3, which is also translocated from the SG to the PVM. SG3 was further localized to knob-like and filamentous structures outside the PVM. Together, these findings suggest that CP2 is secreted to the parasite-host cell interface during invasion and intracellular growth, where it potentially contributes to the formation of the nascent parasitophorous vacuole of Cryptosporidium, together with other SG proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.